NEW YORK, N.Y. — October 2, 2026 — Author Biff Simpson invites readers into a world of scientific possibility, human ambition, and escalating consequences in Tantalus, a biotechnology-driven thriller centered on a discovery capable of changing the future of medicine.

At the heart of the novel is the Hanberry, a genetically engineered biological creation exhibiting extraordinary properties associated with cellular regeneration, immune response, neural repair, viral suppression, and accelerated recovery.

But in Tantalus, the discovery of something miraculous is only the beginning.

As the potential of the Hanberry becomes increasingly apparent, the people surrounding it are confronted with a much larger question: Who should control a scientific breakthrough powerful enough to change human life?

What begins as an extraordinary discovery soon develops into a high-stakes struggle involving science, survival, ownership, responsibility, and the unpredictable consequences of pushing biological innovation beyond familiar boundaries.

Through characters including Peter Hanner, Adam Dent, Judy Nash, Toni Pierce, Edward Barstow, Uncle Ned Dent, and Jason Freedman, Simpson builds a story in which personal motivations collide with the implications of a discovery that may be too valuable — and too powerful — to remain hidden.